Evidence map›Paper›PMID 10901363›Full record

ArticleBritish journal of cancer2000

Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers.

R Gershoni-Baruch, Y Patael, Dagan, A Figer, L Kasinetz, E Kadouri, R Bruchim Bar Sade, E Friedman

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. EMSY promoted the growth and migration of ovarian cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  7. Article
  8. Article
  9. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2008
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

R Gershoni-BaruchDepartment of Genetics, Rambam Medical Center, Bruce Rappoport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Y Patael
Dagan
A Figer
L Kasinetz
E Kadouri
R Bruchim Bar Sade
E Friedman
Rambam Health Care Campus · ILRabin Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The frequency of the APC I1307K mutation and its association with disease pattern was examined in 996 Ashkenazi women consisting of individuals with either sporadic (n = 382) or hereditary (n = 143) breast and/or ovarian cancer; asymptomatic BRCA1/2 mutation carriers (185delAG, 5382insC and 6174delT) (n= 53) and healthy controls (n= 418). The I1307K allele was equally distributed among women with sporadic (17/382; 4.6%) and inherited (10/143; 7%) breast and/or ovarian cancer irrespective of their being diagnosed before or after 42 years of age and among asymptomatic (7/53; 13.2%) and cancer manifesting BRCA1/2 carriers (10/143; 7%). Taken together, the prevalence of the I1307K allele was significantly higher in BRCA1/2 carriers compared to non-BRCA1/2 carriers (17/196; 8.7% and 40/800, 5%; respectively). The high prevalence of the I1307K allele among BRCA1/2 carriers is not associated with increased cancer risk but seems to be genetically connected because of Jewish ancestry.

Indexed as

MutationAdenomatous Polyposis Coli ProteinAdultAgedAged, 80 and overBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCytoskeletal ProteinsFemaleGene FrequencyGenetic MarkersGenetic Predisposition to DiseaseHumansMiddle AgedNeoplasm ProteinsAdenomatous Polyposis Coli ProteinBRCA1 ProteinBRCA2 ProteinCytoskeletal ProteinsGenetic MarkersNeoplasm ProteinsTranscription Factors

Identifiers

PMID10901363
PMCPMC2363478
OpenAlexW1744232948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.